Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Nuedexta, dextromethorphan/quinidine (AVP-923) (formerly Neurodex)
Also known as: formerly Zenvia
print preview
bookmark
share with colleague
General Information
Company
Avanir Pharmaceuticals Inc.
Description
Combination of the NMDA receptor antagonist dextromethorphan with quinidine sulfate, a cytochrome P450 2D6 enzyme inhibitor
Molecular Target
NMDA receptor
;
Sigma-1 receptor
Mechanism of Action
Cytochrome P450 inhibitor; NMDA receptor antagonist
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy